These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10504685)

  • 1. Asia calls for united approach to commerce.
    Saegusa A
    Nat Biotechnol; 1999 Oct; 17(10):946-7. PubMed ID: 10504685
    [No Abstract]   [Full Text] [Related]  

  • 2. Technology transfer and idea commercialization.
    Sheft J
    Nat Biotechnol; 2008 Jun; 26(6):711-2. PubMed ID: 18536695
    [No Abstract]   [Full Text] [Related]  

  • 3. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 4. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 5. New biotech hubs may emerge as industry matures.
    Basu P
    Nat Biotechnol; 2003 Oct; 21(10):1123. PubMed ID: 14520385
    [No Abstract]   [Full Text] [Related]  

  • 6. In-licensing as a business model.
    Schafer DP
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE36-9. PubMed ID: 12089585
    [No Abstract]   [Full Text] [Related]  

  • 7. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 8. Blurred vision.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
    [No Abstract]   [Full Text] [Related]  

  • 9. Millennium and Aventis in unique pact.
    Fletcher L
    Nat Biotechnol; 2000 Aug; 18(8):817. PubMed ID: 10932140
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 11. Top pop(ulation)s: dual, duo or duel?
    Paul M
    Nat Biotechnol; 2007 Nov; 25(11):1327. PubMed ID: 17989690
    [No Abstract]   [Full Text] [Related]  

  • 12. Rising biotech appetite in the East.
    Sheridan C
    Nat Biotechnol; 2006 Nov; 24(11):1305-6. PubMed ID: 17093459
    [No Abstract]   [Full Text] [Related]  

  • 13. What it takes to work together.
    Givens L
    Behav Healthc; 2006 Dec; 26(12):38. PubMed ID: 17233383
    [No Abstract]   [Full Text] [Related]  

  • 14. Health-related biotechnology transfer to Africa: principal-agency relationship issues.
    Kirigia JM; Muthuri LK; Kirigia DG
    Afr J Med Med Sci; 2007; 36 Suppl():81-90. PubMed ID: 17703570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Create products by going virtual.
    Hogan J
    Med Device Technol; 2005 Nov; 16(9):38-9. PubMed ID: 16438448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can you say what your strategy is?
    Collis DJ; Rukstad MG
    Harv Bus Rev; 2008 Apr; 86(4):82-90, 137. PubMed ID: 18435009
    [No Abstract]   [Full Text] [Related]  

  • 17. Ease on down the mobile road.
    Schuerenberg BK
    Health Data Manag; 2004 May; 12(5):74, 76. PubMed ID: 15570728
    [No Abstract]   [Full Text] [Related]  

  • 18. Coalition's dilemma: deciding what's next.
    Moskowitz DB
    Bus Health; 1999 Aug; 17(8):53-4. PubMed ID: 10557392
    [No Abstract]   [Full Text] [Related]  

  • 19. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

  • 20. Value creation and sharing among universities, biotechnology and pharma.
    Edwards MG; Murray F; Yu R
    Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.